Criteria for Stem Cell Transplant and Discontinuation of Therapy

This chapter explores the evolving criteria for candidates eligible for hematopoietic stem cell transplants, noting a decrease in their use in the USA due to the success of new therapies. It highlights key considerations for patients with chronic myeloid leukemia (CML) and the potential for safely discontinuing tyrosine kinase inhibitors under certain conditions.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.